Works matching DE "ALEMTUZUMAB"

Results: 766
    1
    2
    3

    Old drug, new price?

    Published in:
    Nature Reviews Immunology, 2012, v. 12, n. 12, p. 810, doi. 10.1038/nri3348
    By:
    • Bordon, Yvonne
    Publication type:
    Article
    4
    5
    6
    7

    Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation.

    Published in:
    Journal of Pharmaceutical Health Care & Sciences, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s40780-022-00256-9
    By:
    • Katada, Yoshiki;
    • Nakagawa, Shunsaku;
    • Itohara, Kotaro;
    • Suzuki, Takuya;
    • Kato, Ryota;
    • Endo, Hiroki;
    • Sugimoto, Mitsuhiro;
    • Yonezawa, Atsushi;
    • Nakagawa, Takayuki;
    • Ohsumi, Akihiro;
    • Nakajima, Daisuke;
    • Date, Hiroshi;
    • Terada, Tomohiro
    Publication type:
    Article
    8

    Poster.

    Published in:
    Basic & Clinical Pharmacology & Toxicology, 2024, v. 135, p. 25, doi. 10.1111/bcpt.14066
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma.

    Published in:
    Bone Marrow Transplantation, 2014, v. 49, n. 5, p. 671, doi. 10.1038/bmt.2014.4
    By:
    • Avivi, I;
    • Canals, C;
    • Vernant, J-P;
    • Wulf, G;
    • Nagler, A;
    • Hermine, O;
    • Petersen, E;
    • Yakoub-Agha, I;
    • Craddock, C;
    • Schattenberg, A;
    • Niederwieser, D;
    • Thomson, K;
    • Blaise, D;
    • Attal, M;
    • Pfreundschuh, M;
    • Passweg, J;
    • Russell, N;
    • Dreger, P;
    • Sureda, A
    Publication type:
    Article
    25

    EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era.

    Published in:
    Bone Marrow Transplantation, 2014, v. 49, n. 2, p. 280, doi. 10.1038/bmt.2013.170
    By:
    • Fox, C P;
    • Burns, D;
    • Parker, A N;
    • Peggs, K S;
    • Harvey, C M;
    • Natarajan, S;
    • Marks, D I;
    • Jackson, B;
    • Chakupurakal, G;
    • Dennis, M;
    • Lim, Z;
    • Cook, G;
    • Carpenter, B;
    • Pettitt, A R;
    • Mathew, S;
    • Connelly-Smith, L;
    • Yin, J A L;
    • Viskaduraki, M;
    • Chakraverty, R;
    • Orchard, K
    Publication type:
    Article
    26

    Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.

    Published in:
    Bone Marrow Transplantation, 2014, v. 49, n. 1, p. 42, doi. 10.1038/bmt.2013.115
    By:
    • Marsh, J C;
    • Pearce, R M;
    • Koh, M B C;
    • Lim, Z;
    • Pagliuca, A;
    • Mufti, G J;
    • Perry, J;
    • Snowden, J A;
    • Vora, A J;
    • Wynn, R T;
    • Russell, N;
    • Gibson, B;
    • Gilleece, M;
    • Milligan, D;
    • Veys, P;
    • Samarasinghe, S;
    • McMullin, M;
    • Kirkland, K;
    • Cook, G
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation.

    Published in:
    International Journal of Hematology-Oncology & Stem Cell Research, 2021, v. 15, n. 1, p. 51
    By:
    • Barkhordar, Maryam;
    • Kasaeian, Amir;
    • Tavakoli, Sahar;
    • Vaezi, Mohammad;
    • Foumani, Hossein Kamranzadeh;
    • Bahri, Tannaz;
    • Babakhani, Davood;
    • Mirzakhani, Leila;
    • Mousavi, Ashraf;
    • Mousavi, Seied Asadollah;
    • Ghavamzadeh, Ardeshir
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Hematopoietic stem cell transplantation for B-thalassemia major with alemtuzumab.

    Published in:
    Pediatric Hematology & Oncology, 2024, v. 41, n. 4, p. 260, doi. 10.1080/08880018.2023.2296933
    By:
    • Sánchez, Luisanna M.;
    • George, Anil;
    • Friend, Brian D.;
    • Bhar, Saleh;
    • Sasa, Ghadir;
    • Doherty, Erin E.;
    • Craddock, John;
    • Steffin, David;
    • Salem, Baheyeldin;
    • Yassine, Khaled;
    • Omer, Bilal;
    • Martinez, Caridad;
    • Leung, Kathryn;
    • Krance, Robert A.;
    • John, Tami D.
    Publication type:
    Article
    48
    49
    50

    Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide.

    Published in:
    Clinical Epigenetics, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13148-023-01436-6
    By:
    • Chen, Jinghong;
    • Zuo, Zhixiang;
    • Gao, Yan;
    • Yao, Xiaosai;
    • Guan, Peiyong;
    • Wang, Yali;
    • Li, Zhimei;
    • Liu, Zhilong;
    • Hong, Jing Han;
    • Deng, Peng;
    • Chan, Jason Yongsheng;
    • Cheah, Daryl Ming Zhe;
    • Lim, Jingquan;
    • Chai, Kelila Xin Ye;
    • Chia, Burton Kuan Hui;
    • Pang, Jane Wan Lu;
    • Koh, Joanna;
    • Huang, Dachuan;
    • He, Haixia;
    • Sun, Yichen
    Publication type:
    Article